A Phase 2 Study to Evaluate Dose and Duration of Treatment of Drotrecogin Alfa (Activated) Using Serial Measurements of Protein C in Patients with Severe and Multiple Organ Dysfunctions

Project: Research project

Project Details

StatusFinished
Effective start/end date1/1/061/1/14

Funding

  • -